The US FDA has proposed changes to the standards of identity (SOI) for foods to permit the use of salt substitutes.
Product developers would now have the flexibility to work with ingredients that are regulated by the SOI rule.
As SOIs require certain ingredients in the formulation, replacing salt with a salt substitute would be illegal.
There are over 250 SOI foods, including milk, milk chocolate, breads, cheeses and ketchup, with 80 of them specifying salt as a required or an optional ingredient.
The proposed rule does not list permitted salt substitutes but requires them to be “safe and suitable ingredients.” Potassium chloride is an often-used substitute. The agency also acknowledges the functional nature of salt.
According to the FDA, “the extent to which salt can be replaced depends on the ability of salt substitutes to replace the functions of salt in food without compromising the food safety or other essential characteristics of the food.”
The FDA''s 2021 voluntary sodium reduction targets for processed, packaged, and prepared foods seeks to reduce Americans' average daily intake of sodium from the current 3,300mg per day to 3,000 per day and ultimately to 2,300mg per day.
The proposed rule, "Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods," should be published shortly in the Federal Register, after which the industry and public will have 120 days to comment.


Japan Approves Record ¥122.3 Trillion Budget as Takaichi Seeks Fiscal Balance
Taiwan Stock Market Ends Higher as Semiconductor and Energy Shares Lead Gains
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Oil Prices Rise on Venezuela Sanctions and Nigeria Airstrikes Despite Annual Losses
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
BOJ Minutes Reveal Growing Debate Over Interest Rate Hikes and Inflation Risks
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



